COVID-19-associated new-onset hyperglycaemia: a reversible entity or persistent risk?
Postgrad Med J
.
2022 Mar 1;98(e2):e125-e126.
doi: 10.1136/postgradmedj-2021-140807.
Authors
Liza Das
1
,
Sanjay K Bhadada
1
Affiliation
1
Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
PMID:
37066532
DOI:
10.1136/postgradmedj-2021-140807
No abstract available
Keywords:
COVID-19; diabetes & endocrinology.
MeSH terms
Blood Glucose
COVID-19* / complications
Diabetes Mellitus*
Humans
Hyperglycemia* / complications
Risk Factors
Substances
Blood Glucose